Home
Choose language  
Pharmacoreport Pharmacoreport
www.pharmacoreport .com is a news site providing information about the top international pharmaceutical companies. This website will also provide other information about these pharmaceuticals like their address and locations, corporate history, clinical trials, annual report, employees, careers and jobs, health care products, research, sales, shares, dividend & stock price, and patients’ assistance program.
 
AMGen   AMGen

 


AMGen Incorporation is the global biotechnology enterprise which was established in the year 1980. The headquarters of AMGen Inc. are situated at the Newbury Park – the part of Thousand Oaks in California – the United States. The company is supposed to be the biggest autonomous biotechnology enterprise which employs around 15,000 people.

The term AMGen is the combination of the original name of the company which broadly denotes Applied Molecular Genetics which gradually became the formal name of the company during 1983 – precisely 3 years of the company’s incorporation as well as the first ever public offerings inadvertently.  

AMGen is also reported to have strong history of taking over a few of the most leading corporate enterprises such as: Synergen Inc during 1994, Kinetix Pharmaceuticals Inc during 2000, Immunex Corporation during 2002, Tularik Inc during 2004, Abgenix Inc during 2006, Avidia Inc also during 2006, Ilypsa Inc and Alantos Pharmaceuticals Holdings Inc both during the current year i.e. 2007. 

It is reported that for poising as the most future-oriented enterprise, Business Week has AMGen in the 4th position on the S&P 500 on the strength of ratio calculations made apparently on research and development expenses or budgets along with capital spending, and the total outlays by the contenders. AMGen showed the fourth highest ratio figuring as 506:1000. The company is also the member of the Pennsylvania Bio Commerce Organization.

The major products of AMGen include: Epogen, Aranesp, Enbrel, Kineret, Neulasta, Neupogen, Senispar and Mimpara of which Epogen and Neupogen were the first two biopharmaceutical products of the company when they were launched in the markets. 


Metsubishi Pharma , Hofmann_La Roche , EEli Lilly and Company , Shienogi and Co , Prokter and Gamble , Pizer , Teisho Pharmaceutical , Dr Redys Laboratories Ltd , Taakeda Pharmaceutical Co , Daichi Pharmaceutical Co
Latest News About amgen
GENETICS INSTITUTE, AMGEN SETTLE
GENETICS INSTITUTE concluded its old patent infringement debate with AMGEN inc. to pay $14 million in damages at AMGEN, agreeing on. REMOVES unanimously....More
J&J, Bristol-Myers, Amgen on deck
BOSTON (MarketWatch) -- Johnson and Johnson, Bristol-Myers Squibb and Amgen are to be reported on cover, quarter quarter salary next week, when Eli lily and. sind...More
AMGEN SHARES DROP SHARPLY DURING AFTER-HOURS TRADING
SHARES OF BIOTECHNOLOGY firm AMGEN inc. fell in AFTER HOURS ACTING yesterday... AMGEN has the disclosure AFTER regular TRADE HOURS, and the share made.....More
Amgen net rises 20% on drug for anemia
BOSTON Amgen, the worldand the largest biotechnology firm, Thursday said that... the agreement with Genentech, a rival, will give Amgen access to a sentence of.....More
Amgen cuts 70 to 80 Boulder workers "Across-the-board&...
Amgen inc., the biotechnology giant who constructs a manufacture plant in ... Amgen adjusts approximately 450 people in boulder, many, of which searches, .....More
Amgen& Fourth Quarter 2006 Revenue Increased 17% to $3.8...
1, 2006, Amgen began to record edition, that was connected with employee share, ... andquot; Amgen another year had incomes strong and has salary growth during we. on place....More
Amgen& Future
Amgen (Nasdaq: AMGN) has lynch rejected today on negative comments of Merrill, ... Anyway the matter that surrounds Amgen is, this: vis-à-vis state has the firm.....More
Final Teams Announced for 2007 Amgen Tour of California Professional...
..More
2 Biotechnology Stocks Dive As Nerve Disease Drug Fails
Through LAWRENCE M. FISHERMAN inc. pharmaceutical share by Regeneron and Amgen inc. sharply fell... $2,8125 is Amgen shares, or nearly 5 percent, pleased to $55,0625. .....More
Amgen net edges higher; anemia, arthritis treatments sales rise -...
On that basis, Amgen became to earn 95 cents a share on incomes of $3.77,. erwartet. Regard ahead, has Amgen prediction the salaries of 2007 from $4.30 to $4.50 a. on place....More